Xeris Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.69-$3.87 |
Market Cap | $538.1M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $187.3M |
Revenue Growth (YoY) | 12.3% |
Gross Profit (12 Mos) | $87.6M |
Diluted EPS | -$0.42 |
News
See moreYahoo Finance • 2 years ago
Xeris Biopharma CEO reveals impact of CSO's departure and exciting future plans
Yahoo Finance • 2 years ago
Xeris Biopharma Announces First Participant Dosed in a Phase 2 Clinical Study of Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121) in Patients With Hypothyroidism
Yahoo Finance • 2 years ago
Xeris Biopharma Announces Issuance of U.S. Patent Covering XeriSol™ Formulations
Yahoo Finance • 2 years ago
Subdued Growth No Barrier To Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) With Shares Advancing 61%
About
CEO | Mr. John P. Shannon |
Address | 180 North LaSalle Street, Chicago, IL, United States, 60601 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 377 |
